FGF21 has demonstrated the capacity to mitigate arthritis severity through the suppression of humoral and cellular immune responses, as well as by dampening the expression of pro-inflammatory cytokines in the cases of rheumatoid arthritis (RA) (335, 336). This evidence concerns the gene FGF21 and rheumatoid arthritis.